Stem Cell Assays Market Report 2022-2027: Increasing Awareness About Therapeutic Potency of Stem Cells Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The stem cell assay market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period.

The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, the launch of new stem cell analysis systems such as flow cytometers, and increase in R&D expenditure by biopharmaceutical and biotechnology companies.

The viability/cytotoxicity assays accounted for the largest share of the type segment in the stem cell assays market in 2021

Cell viability assays help to determine the number of live and dead cells in a culture medium. The viability/cytotoxicity assays include various types such as tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, and other viability/cytotoxicity assays. The cell viability/cytotoxicity market is likely to be driven by rising R&D spending on stem cell research, an increase in demand for stem cell assays in drug discovery, and development of new stem cell therapies..

The adult stem cells segment accounted for the largest share of the cell type segment in the stem cell assays market in 2021.

Adult stem cells account for the largest share of the stem cell assay market. The adult stem cells include mesenchymal stem cells, induced pluripotent stem cells, hematopoietic stem cells, umbilical cord stem cells, and neural stem cells. The growth of the adult stems cells segment is driven by the increasing usage of adult stem cells in regenerative medicine and the development of advanced therapies.

Asia Pacific: The fastest-growing region in the stem cell assays market

The Asia Pacific is estimated to be the fastest-growing segment of the market, owing to the rising prevalence of cancer & other diseases, increasing R&D spending on biopharmaceutical projects, and focus on developing stem cell-based therapies. In this region, China and Japan are the largest markets.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Stem Cell Assays Market Overview

4.2 North America: Stem Cell Assays Market, by Product & Service and Country (2021)

4.3 Stem Cell Assays Market Share, by Type, 2022 Vs. 2027

4.4 Stem Cell Assays Market Share, by Application, 2021

4.5 Stem Cell Assays Market: Geographic Growth Opportunities

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 Increasing Awareness About Therapeutic Potency of Stem Cells

5.2.1.2 Increasing Funding for Stem Cell Research

5.2.1.3 Rising Demand for Cell-Based Assays in Drug Discovery

5.2.1.4 Collaborations and Agreements Among Market Players for Stem Cell Assay Products & Services

5.2.1.5 Rising Incidence of Cancer

5.2.2 Restraints

5.2.2.1 Issues in Embryonic Stem Cell Research

5.2.2.2 High Cost of Stem Cell Analysis Instruments

5.2.3 Opportunities

5.2.3.1 Emerging Economies

5.2.3.2 Government Initiatives to Boost Stem Cell Research

5.2.4 Challenges

5.2.4.1 Lack of Infrastructure for Stem Cell Research in Emerging Economies

5.2.4.2 Dearth of Trained and Skilled Professionals

5.3 Ranges/Scenarios

5.4 Impact of COVID-19 on Stem Cell Assays Market

5.5 Trends/Disruptions Impacting Customers' Business

5.6 Pricing Analysis

5.6.1 Average Selling Prices of Products Offered by Key Players

5.6.2 Average Selling Price Trend

5.7 Technology Analysis

6 Stem Cell Assays Market, by Type

6.1 Introduction

6.2 Viability/Cytotoxicity Assays

6.3 Isolation & Purification Assays

6.4 Cell Identification Assays

6.5 Proliferation Assays

6.6 Differentiation Assays

6.7 Function Assays

6.8 Apoptosis Assays

7 Stem Cell Assays Market, by Cell Type

7.1 Introduction

7.2 Adult Stem Cells

7.3 Human Embryonic Stem Cells

8 Stem Cell Assays Market, by Product & Service

8.1 Introduction

8.2 Instruments

8.3 Kits

8.4 Services

9 Stem Cell Assays Market, by Application

9.1 Introduction

9.2 Regenerative Medicine & Therapy Development

9.3 Drug Discovery & Development

9.4 Clinical Research

10 Stem Cell Assays Market, by End-User

11 Stem Cell Assays Market, by Region

12 Competitive Landscape

13 Company Profiles

Companies Mentioned

• Aat Bioquest, Inc
• Abcam plc
• Agilent Technologies, Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• Bio-Techne Corporation
• Biotium
• Bps Bioscience, Inc
• Cell Biolabs, Inc
• Charles River Laboratories
• Creative Bioarray
• Danaher
• Enzo Biochem Inc
• Fujifilm Holdings Corporation
• Geno Technology Inc
• Hemogenix Inc
• Lonza Group
• Merk KGaA
• Miltenyi Biotec
• Perkinelmer Inc
• Promega Corporation
• Promocell GmbH
• Reachbio Research Labs
• Stemcell Technologies
• Takara Bio Inc
• Thermo Fisher Scientific Inc

For more information about this report visit https://www.researchandmarkets.com/r/hvgp4o

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900